Kevin Bitterman
Partner at Atlas Venture
Cambridge, Massachusetts
Overview
Work Experience
Partner
2017 - Current
Atlas Venture creates and invests in biotech startup companies with seed and early stage venture investments.
Board of Directors
2022
Board of Directors
2019
Remix Therapeutics is a biotechnology company that is working on developing small molecule medicines.
Raised $211,000,000.00 from Surveyor Capital, The Column Group, Atlas Venture, Alexandria Venture Investments, Casdin Capital, ARCH Venture Partners, Foresite Capital, WTT Investment and Willett Advisors LLC.
Board of Directors
2020
Board of Directors
2020
Kinaset Therapeutics is a biopharma company that focuses on advancement of novel drugs in areas of unmet medical needs.
Raised $41,500,000.00 from Gimv, Atlas Venture and 5AM Ventures.
Board Of Directors
2017
Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.
Raised $792,800,000.00 from Hercules Capital.
Member Board of Trustees
2017
Isabella Stewart Gardner Museum showcases a remarkable art collection along with immersive galleries and a flower-filled courtyard.
Board of Directors
2021 - 2024
Mariana Oncology is a biotechnology research industry.
Raised $250,000,000.00 from RA Capital Management, Nextech Invest, Surveyor Capital, Atlas Ventures, Forbion Capital Partners, Deep Track Capital, Eli Lilly and Access Biotechnology.
Board Member
2013 - 2023
Board of Directors
2018 - 2021
Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.
Raised $951,100,000.00 from Hercules Capital.